Effect of Time Shift of Transcranial Direct Current Stimulation (tDCS) for Treatment of Acute Tinnitus

A

Antwerp University Hospital (UZA)

Status

Unknown

Conditions

Tinnitus

Treatments

Other: transcranial direct current stimulation (tDCS)

Study type

Interventional

Funder types

Other

Identifiers

NCT01886729
EC 11/18/146

Details and patient eligibility

About

The treatment for patients with acute tinnitus consists of Methylprednisolone and hyperbaric oxygen therapy. For this study transcranial direct current stimulation (tDCS) was added to the protocol. The purpose is to determine the effect of the time shift of tDCS. Two conditions will be compared: tDCS simultaneously with the hyperbaric oxygen therapy or tDCS 3 weeks after the start of the tinnitus. An audiological testing will be performed at the day of admission, after 3 weeks, 6 weeks and 12 weeks.

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age between 18 and 50 years
  • presence of acute tinnitus or worsening of tinnitus caused by otogenic disease
  • registration in UZA within 48 hours after start tinnitus
  • VAS-score ≥ 4
  • ability to understand and sign informed consent

Exclusion criteria

  • history of epileptic seizures
  • severe organic comorbidity
  • psychiatric disorders or a history of psychiatric disorders with psychotic symptoms
  • Pace maker
  • pregnancy

Trial design

0 participants in 2 patient groups

tDCS simultaneously with hyperbaric oxygen therapy
Active Comparator group
Treatment:
Other: transcranial direct current stimulation (tDCS)
tDCS 3 weeks after start tinnitus
Active Comparator group
Treatment:
Other: transcranial direct current stimulation (tDCS)

Trial contacts and locations

1

Loading...

Central trial contact

Sarah Rabau

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems